Tangshan epidemic risk classification latest Tangshan epidemic risk classification

Updated: May 25, 2022

Tangshan epidemic risk classification:

According to the State Council's response to the new coronavirus pneumonia epidemic joint prevention and control mechanism on the scientific division, precision prevention and control and other work requirements, since May 25, 2022, Tangshan City, Lunan District, Tiandi Fukunong Fruit Market adjusted to the low-risk areas. After the adjustment, the whole area of Tangshan City is a low-risk area.

Related reading:

In the normalization of the epidemic prevention and control, in accordance with the key populations "should be examined as much as possible", other populations "willing to examine as much as possible" requirements for nucleic acid testing, especially in the provincial capitals and ten million people in the city to establish walking 15-minute nucleic acid "sampling circle", the purpose is to facilitate the people close to the convenience of nucleic acid sampling, in order to "early detection", improve the sensitivity of the epidemic monitoring and early warning.

At present, a number of domestic cities and regions have been exploring the implementation of regular nucleic acid testing, such as Shenzhen, Hangzhou, Dalian, Hefei, and Jiangxi Province, Hubei Province, a number of cities. These cities, according to the local reality, reasonable distribution of nucleic acid sampling points, organizing the public for a minimum of 48 hours, the longest 7 days for a nucleic acid test, in general, the operation seems to be stable, and has achieved better results. In particular, in some places, through joint procurement of nucleic acid testing reagents and other consumables in many places, the cost of testing has been further suppressed and the price of testing has been lowered, which has facilitated the orderly development of normalized testing work. It is also understood that the relevant departments of the State Council is urging the study to further guide localities to reduce the cost and price of nucleic acid testing.